Annual EBIT:
-$425.74M-$34.25M(-8.75%)Summary
- As of today, AGIO annual earnings before interest & taxes is -$425.74 million, with the most recent change of -$34.25 million (-8.75%) on December 31, 2024.
- During the last 3 years, AGIO annual EBIT has fallen by -$47.32 million (-12.50%).
- AGIO annual EBIT is now -2459.90% below its all-time high of -$16.63 million, reached on December 31, 2011.
Performance
AGIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$116.87M+$10.19M(+8.02%)Summary
- As of today, AGIO quarterly earnings before interest & taxes is -$116.87 million, with the most recent change of +$10.19 million (+8.02%) on September 30, 2025.
- Over the past year, AGIO quarterly EBIT has dropped by -$14.06 million (-13.67%).
- AGIO quarterly EBIT is now -3743.05% below its all-time high of $3.21 million, reached on September 30, 2014.
Performance
AGIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$475.59M-$14.06M(-3.05%)Summary
- As of today, AGIO TTM earnings before interest & taxes is -$475.59 million, with the most recent change of -$14.06 million (-3.05%) on September 30, 2025.
- Over the past year, AGIO TTM EBIT has dropped by -$68.61 million (-16.86%).
- AGIO TTM EBIT is now -8934.78% below its all-time high of -$5.26 million, reached on March 31, 2012.
Performance
AGIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AGIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -8.8% | -13.7% | -16.9% |
| 3Y3 Years | -12.5% | -28.3% | -20.5% |
| 5Y5 Years | -34.6% | -45.6% | -33.4% |
AGIO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -12.5% | at low | -29.0% | +8.0% | -27.0% | at low |
| 5Y | 5-Year | -34.6% | at low | -45.6% | +8.0% | -41.6% | at low |
| All-Time | All-Time | -2459.9% | at low | -3743.1% | +8.0% | -8934.8% | at low |
AGIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$116.87M(+8.0%) | -$475.59M(-3.0%) |
| Jun 2025 | - | -$127.06M(-19.2%) | -$461.53M(-4.8%) |
| Mar 2025 | - | -$106.63M(+14.7%) | -$440.29M(-3.4%) |
| Dec 2024 | -$425.74M(-8.7%) | -$125.04M(-21.6%) | -$425.74M(-4.6%) |
| Sep 2024 | - | -$102.81M(+2.8%) | -$406.98M(-0.5%) |
| Jun 2024 | - | -$105.82M(-14.9%) | -$405.06M(-3.1%) |
| Mar 2024 | - | -$92.07M(+13.4%) | -$392.95M(-0.4%) |
| Dec 2023 | -$391.49M(-0.6%) | -$106.28M(-5.3%) | -$391.49M(-1.8%) |
| Sep 2023 | - | -$100.90M(-7.7%) | -$384.38M(-2.6%) |
| Jun 2023 | - | -$93.70M(-3.4%) | -$374.57M(+1.0%) |
| Mar 2023 | - | -$90.61M(+8.6%) | -$378.51M(+2.7%) |
| Dec 2022 | -$389.05M(-2.8%) | -$99.17M(-8.9%) | -$389.05M(+1.4%) |
| Sep 2022 | - | -$91.09M(+6.7%) | -$394.70M(+0.0%) |
| Jun 2022 | - | -$97.64M(+3.5%) | -$394.76M(-1.7%) |
| Mar 2022 | - | -$101.14M(+3.5%) | -$388.35M(-2.6%) |
| Dec 2021 | -$378.42M(-12.7%) | -$104.83M(-15.0%) | -$378.42M(-5.4%) |
| Sep 2021 | - | -$91.15M(+0.1%) | -$358.92M(-3.1%) |
| Jun 2021 | - | -$91.22M(-0.0%) | -$348.06M(-2.3%) |
| Mar 2021 | - | -$91.22M(-6.9%) | -$340.10M(-1.2%) |
| Dec 2020 | -$335.92M(-6.2%) | -$85.33M(-6.3%) | -$335.92M(+5.8%) |
| Sep 2020 | - | -$80.29M(+3.6%) | -$356.51M(+7.5%) |
| Jun 2020 | - | -$83.26M(+4.3%) | -$385.28M(+7.4%) |
| Mar 2020 | - | -$87.03M(+17.8%) | -$415.88M(+2.5%) |
| Dec 2019 | -$316.27M(+8.6%) | -$105.93M(+2.9%) | -$426.33M(-2.3%) |
| Sep 2019 | - | -$109.06M(+4.2%) | -$416.76M(-2.4%) |
| Jun 2019 | - | -$113.86M(-16.8%) | -$406.86M(-11.2%) |
| Mar 2019 | - | -$97.48M(-1.2%) | -$365.95M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$346.03M(-7.9%) | -$96.36M(+2.8%) | -$362.48M(-1.7%) |
| Sep 2018 | - | -$99.16M(-35.9%) | -$356.25M(-6.0%) |
| Jun 2018 | - | -$72.95M(+22.4%) | -$336.11M(+3.4%) |
| Mar 2018 | - | -$94.01M(-4.3%) | -$347.76M(-8.4%) |
| Dec 2017 | -$320.79M(-59.6%) | -$90.13M(-14.1%) | -$320.79M(-11.4%) |
| Sep 2017 | - | -$79.02M(+6.6%) | -$288.07M(-5.7%) |
| Jun 2017 | - | -$84.60M(-26.2%) | -$272.57M(-11.5%) |
| Mar 2017 | - | -$67.05M(-16.8%) | -$244.44M(-21.6%) |
| Dec 2016 | -$200.99M(-69.3%) | -$57.41M(+9.6%) | -$200.99M(-9.0%) |
| Sep 2016 | - | -$63.51M(-12.5%) | -$184.47M(-14.3%) |
| Jun 2016 | - | -$56.47M(-139.3%) | -$161.44M(-17.8%) |
| Mar 2016 | - | -$23.59M(+42.3%) | -$137.10M(-15.5%) |
| Dec 2015 | -$118.70M(-119.3%) | -$40.90M(-1.0%) | -$118.70M(-13.6%) |
| Sep 2015 | - | -$40.48M(-26.0%) | -$104.53M(-71.8%) |
| Jun 2015 | - | -$32.13M(-518.5%) | -$60.85M(-29.3%) |
| Mar 2015 | - | -$5.20M(+80.6%) | -$47.04M(+13.1%) |
| Dec 2014 | -$54.13M(-39.2%) | -$26.73M(-933.1%) | -$54.13M(-36.5%) |
| Sep 2014 | - | $3.21M(+117.5%) | -$39.65M(+26.5%) |
| Jun 2014 | - | -$18.33M(-49.2%) | -$53.92M(-22.2%) |
| Mar 2014 | - | -$12.28M(-0.3%) | -$44.12M(-13.5%) |
| Dec 2013 | -$38.88M(-69.1%) | -$12.24M(-10.6%) | -$38.88M(-46.0%) |
| Sep 2013 | - | -$11.07M(-29.8%) | -$26.64M(-71.1%) |
| Jun 2013 | - | -$8.53M(-21.0%) | -$15.57M(-18.2%) |
| Mar 2013 | - | -$7.05M(-15.1%) | -$13.17M(-15.6%) |
| Dec 2012 | -$23.00M(-38.3%) | - | - |
| Jun 2012 | - | -$6.12M(-16.3%) | -$11.39M(-116.3%) |
| Mar 2012 | - | -$5.26M | -$5.26M |
| Dec 2011 | -$16.63M | - | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AGIO is -$425.74M
What is the all-time high annual EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$16.63M
What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AGIO annual earnings before interest & taxes has changed by -$34.25M (-8.75%)
What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AGIO is -$116.87M
What is the all-time high quarterly EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $3.21M
What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AGIO quarterly earnings before interest & taxes has changed by -$14.06M (-13.67%)
What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AGIO is -$475.59M
What is the all-time high TTM EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$5.26M
What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AGIO TTM earnings before interest & taxes has changed by -$68.61M (-16.86%)